Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0000908834-26-000532

Stakes reported in this filing

Reporting person Shares Of the class
Farallon Capital Management, L.L.C. 950,000 3.3%
Dapice Joshua J. 950,000 3.3%
Dreyfuss, Philip D. 950,000 3.3%
Dunn Hannah E. 950,000 3.3%
Gehani, Varun N. 950,000 3.3%
Giauque, Nicolas 950,000 3.3%
Husen, Avner A. 950,000 3.3%
Kim, David T. 950,000 3.3%
Linn, Michael G. 950,000 3.3%
Luo Patrick (Cheng) 950,000 3.3%
Roberts, Jr., Thomas G. 950,000 3.3%
Saito Edric C. 950,000 3.3%
Short Daniel S. 950,000 3.3%
Spokes, Andrew J. M. 950,000 3.3%
Warren, John R. 950,000 3.3%
Wehrly, Mark C. 950,000 3.3%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…